DYN

Dyne Therapeutics (DYN)

Dyne Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:DYN

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/23	10:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/23	05:30	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/22	20:59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/22	09:39	GlobeNewswire Inc.	Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/21	07:00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/21	05:24	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/21	05:01	GlobeNewswire Inc.	Dyne Therapeutics Announces Proposed Public Offering of Common Stock	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/20	20:37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/20	19:30	GlobeNewswire Inc.	Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/19	21:00	GlobeNewswire Inc.	Dyne Therapeutics to Host Virtual Investor Event to Review New Clinical Data from the ACHIEVE and DELIVER Trials Tomorrow, May 20 at 8:00 a.m. ET	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/18	10:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/18	10:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/18	10:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/17	05:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/17	05:23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/17	05:18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/03	05:10	GlobeNewswire Inc.	Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/28	05:05	GlobeNewswire Inc.	Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/27	21:30	GlobeNewswire Inc.	Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/25	20:30	GlobeNewswire Inc.	Dyne Therapeutics Announces CEO Transition	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/13	20:30	GlobeNewswire Inc.	Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/12	06:36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/12	06:35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/12	06:35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/09	06:53	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/08	10:19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/08	10:18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/08	10:16	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/05	22:22	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/05	21:41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DYN	Dyne Therapeutics Inc